Analytix Healthcare Solutions Will be Exhibiting at HOMES 2021

Analytix Healthcare Solutions will be joining the virtual Home Medical Equipment and Services Association of New England (HOMES) 2021 Winter Conference. The virtual two-week event will be held from February 25 - March 5, 2021, and offer educational content and exciting events.

HOMES is the regional trade association for providers of home medical equipment and supplies, home oxygen and infusion therapy, and complex rehabilitation technology. The HOMES conferences provide the members with best practice content in communication, education, legislative leadership, as well as networking opportunities to better navigate the medical equipment and services industry.

Analytix Healthcare Solutions (https://www.analytixhealthcaresolutions.com/) will showcase its full range of comprehensive medical billing services that can be combined to provide end-to-end customizable solutions. Visit our virtual booth to learn more about how Analytix’s advanced technology and industry expertise can reduce the administrative burden on your staff and boost both revenue and productivity. Our experienced Medical Billing team collaborates with HME practices to develop integrated, simplified solutions designed to optimize your revenue cycle management.

We help HME providers improve their processes at every step of revenue cycle management so you are collecting every earned dollar. Our team of trained experts manage follow-ups, handle tedious administrative tasks, and ensure error-free transactions leading to faster claims processing and increased collection rates. This allows our clients to focus on strategically growing their business, while we manage the daily workflow and streamline processes.

ABOUT ANALYTIX

Analytix (https://www.analytix.com) is a one-stop integrated solutions provider delivering high-quality services consistently, cost-effectively, and collaboratively. Our extensive experience, combined with our deep industry knowledge and technical expertise, allows us to develop customizable solutions. Analytix's cross-disciplinary domain expertise includes Accounting & Finance, Medical Billing, IT, and AV. Analytix  created Insights360, a management portal that  integrates application tools and accounting services to help specialized industries better manage their finances and operations.

New Stargardt Disease Treatment Improves Vision

Stargardt Disease is the most common inherited macular degeneration, typically starting at a young age and progressively worsening to legal blindness. This can affect many activities in a person’s life, causing difficulty with reading, school, work, driving and seeing faces.  Eye doctors have not been able to offer any potential treatment for improvement- until now.  MD Stem Cells has just published results in the highly respected journal Medicines in a special issue: Stem Cells in Eye Research and Ophthalmology- Current Advances and Future Directions. The doctors conducting the Stem Cell Ophthalmology Treatment Study (SCOTS2) now have very encouraging data for patients with Stargardt Disease. 

The Stem Cell Treatment Ophthalmology Study- both SCOTS and SCOTS2 is using the patient’s own bone marrow stem cells (BMSC) for treating optic nerve and retinal disease. The study is Institutional Board Approved and National Institutes of Health registered on www.clinicaltrials.gov  NCT 03011541. A number of different optic nerve diseases including NAION, LHON, DOA, optic atrophy; as well as retinal diseases including Serpiginous, Cone-Rod, Retinitis Pigmentosa, Ushers, dry AMD and now Stargardt have shown benefit.  MD Stem Cells has worked to ascertain the safest, most effective approach to Stargardt Disease using BMSC - with gratifying success.   

In the 34 eyes treated, vision improved in 61.8% and remained stable in 23.5%-  positive results in over 84% of eyes.  As might be expected, some eyes continued to worsen as a result of the disease. The results were highly statistically significant- meaning that the treatment was overwhelmingly likely to be responsible for the vision benefit. The average improvement across all eyes treated was 17.96% (95% CI, 16.39 to 19.53%).  Reviewing the overall results, 76.5% of patients showed improvement in one or both eyes, 17.6% showed no net loss and only 1 patient continued to worsen from their disease- so improvement or stability in over 94% of patients.  This is similar to the results in dry Age Related Macular Degeneration.

“ This makes sense given that both Stargardt and dry AMD are primarily diseases of the macula or central part of the retina” says Dr. Levy, Chair and Study Director for SCOTS2. “Although dry AMD is does not typically start until late in life, and Stargardt is early, both affect the support layer of the retina called the Retinal Pigment Epithelium.  Therefore, we can postulate that one way the Bone Marrow Derived Stem Cells (BMSC) that we are using can benefit the central vision is by helping this layer of the retina”.

SCOTS and now SCOTS2 have been evaluating BMSC in the treatment of optic nerve and retinal disease for over 7 years.  The physicians involved with MD Stem Cells now have 15 world class medical and scientific publications primarily in ophthalmology, but also regarding their neurology study. This is vastly more than any other stem cell research group in this field- which is important to patients seeking experienced providers. 

Dr. Levy concludes: “as we continue SCOTS 2, we can conclude that patients with Stargardt Disease choosing to participate in the study have a strong likelihood of either improving or stabilizing their vision. ”

About MD Stem Cells

Patients may receive information about SCOTS 2 by emailing This email address is being protected from spambots. You need JavaScript enabled to view it., using the contact us page on www.mdstemcellscom, or calling 203-423-9494. The Stem Cell Ophthalmology Study 2 is enrolling patients with different retina and optic nerve diseases. MD Stem Cells has no grant support and is not a pharmaceutical company; these are patient sponsored studies and the patients pay for both treatment and travel.

Graphic Stargardt Disease

Boston Cannabis Dispensary Explains The Benefits Of Cannabis Cartridges

Boston, Massachusetts (release-news ) February 11, 2021 - Pure Oasis, a Boston Cannabis Dispensary, has recently released a new educational resource that focuses on explaining the benefits of cannabis cartridges. The new article is guided by Boston's cannabis experts at Pure Oasis who have extensive experience helping to give customers an unparalleled dispensary experience and access to the latest and greatest cannabis products. They hope that this new blog will help readers get a better understanding of the advantage of using cannabis cartridges and why they are so popular.

Pure Oasis offers readers some valuable information regarding cannabis cartridges that helps to explain why these items are so popular at their dispensary. In the article, they begin by explaining what pre-filled cartridges are and the different types of products they have in this category. They then go on to detail some of the benefits of these products including their convenience, their portability, the ability to easily control the dosage, the variety of strains and flavors to choose from, and more. The team at Pure Oasis hopes that this article will help readers get a better idea of what cannabis cartridges are and why they have become a mainstay item in their shop.

While this new article focuses on explaining the advantages of using cannabis cartridges, Pure Oasis's website provides readers with more information regarding their team, experience, as well as a full list of service offerings. Pure Oasis is the first dispensary in Boston and offers an extensive selection of the finest cannabis products which include flower, concentrate, pre-rolls, edibles, accessories, and more. Their team takes pride in being able to make every patient's experience in their shop easy and fun. They are well-known in the area for their high level of expertise and customer service

With the addition of this new article, the team at Pure Oasis hopes that readers will have a better understanding of the many benefits of cannabis cartridges and why they are a great choice in their shop. For more information, contact the cannabis experts at Pure Oasis today at 617-420-6837 or visit their website at https://www.mypureoasis.com/. Their shop is located at 430 Blue Hill Avenue in Boston, MA 02121.

###

Nic’s Keto Diet may improve markers of cardiovascular Health

Prof. Nikolaos Tzenios PH.D. may have found the golden grail of Health and the optimal diet where eating a fatty diet reduces body weight and improves cardiovascular health markers.

The high-quality clinical research organization "KGK Science" Canada investigated Nic's Keto Diet's efficacy on cardiovascular Health in an open-label clinical study.
 
"KGK Science" examined healthy men and women with mildly elevated LDL cholesterol levels over a period of 140 days. The study's findings have shown that participants had a significant 4.41% reduction in body fat percentage. Participants body weight was significantly reduced by 8.55kg.

After five months of adherence to the diet plan, participants showed a significant decrease in their total cholesterol and LDL cholesterol, an increase in the HDL cholesterol, the "good cholesterol," and a significant reduction in blood sugar levels. Overall, the study results suggest that Nic's Keto Diet may be used to improve body composition and markers of cardiovascular Health.

Professor Nikolaos Tzenios is a Professor of Public Health, Member of the European Medical Association's Scientific board. Fellow of The Royal Society for Public Health (UK), ASSOCIATE ACADEMICIAN of the International Academy of Social Sciences, Member of the AMERICAN ACADEMY OF ANTI-AGING MEDICINE, Member of the American Academy of Regenerative Medicine, Member of The European Academy of Allergy and Clinical Immunology, Member of the Royal Society of Biology.
 
 

HBP 9284 2

 

DC Addiction Recovery Center Educates On The Integrated Behavioral Model

Washington, DC (release-news ) January 19, 2021 - Aquila Recovery Clinic, a DC addiction recovery center, recently released a blog educating on the integrated behavioral model. The new article is guided by the addiction recovery experts at Aquila who strive to provide help to those who need it most. They have designed this new article to help provide important information on a very important aspect of their recovery methods.

Aquila Recovery Clinic offers readers some valuable information regarding the integrated behavioral model of therapeutic treatment In the article, they provide some details about this model of treatment and also explain how it was created including the theory of planned behavior (TPB) and the Theory of Reasonable Action (TRA). They go on to explain who the integrated behavioral models are for and how they can be of such great help. Their team of trained experts understands the difficulty of this process and believes in giving you the best chance at success using the most proven methods in the field.

While this new article focuses on explaining the details surrounding the integrated behavioral model of treatment, their website provides further information regarding their team, experience, as well as a full list of addiction recovery services. Aquila Recovery offers family programs, intensive outpatient programs, cognitive behavioral therapy, integrated care, trauma-informed care, and more. Aquila's intensive outpatient rehab clinic brings a fresh and evidence-based treatment modality for individuals experiencing alcohol or drug problems in the area of Washington, DC. They strive to improve outcomes by reaching people early that may be having difficulty with addicting substances.

With the addition of this new blog, the team at Aquila hopes that readers will have a better understanding of the benefits of the integrated behavioral model of treatment. For more information, contact the addiction recovery professionals at Aquila today at 202-618-9125 or visit their website at https://www.aquilarecovery.com/. Their offices are located at 5101 Wisconsin Ave. NW, Suite 325, in Washington, DC 20016.

###